Enhanced elimination of ciprofloxacin after multiple-dose administration of rifampin to rabbits
Open Access
- 1 April 1989
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 33 (4) , 589-590
- https://doi.org/10.1128/aac.33.4.589
Abstract
The combination of ciprofloxacin and rifampin is potentially useful for the treatment of selected infections. However, rifampin may induce the metabolism of ciprofloxacin. Ciprofloxacin was given in single doses to healthy rabbits before and after six daily doses of intramuscular rifampin. Total clearance of ciprofloxacin increased from 0.96 +/- 0.32 (standard deviation) to 1.57 +/- 0.63 liters/h per kg (P less than 0.05). This change in elimination is potentially significant for the outcome of experimental infections in rabbits.This publication has 11 references indexed in Scilit:
- Correlation of Antimicrobial Pharmacokinetic Parameters with Therapeutic Efficacy in an Animal ModelThe Journal of Infectious Diseases, 1988
- Mycobacterium avium Complex InfectionThe Journal of Infectious Diseases, 1988
- Altered pharmacokinetic disposition of ciprofloxacin and vancomycin after single and multiple doses in rabbitsAntimicrobial Agents and Chemotherapy, 1987
- Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria.1987
- Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin.1987
- The antimicrobial activity of ciprofloxacin against Legionella species and the treatment of experimental Legionella pneumonia in guinea pigsJournal of Antimicrobial Chemotherapy, 1986
- Rifampin Drug InteractionsArchives of internal medicine (1960), 1984
- The Antimicrobial Activity of Rifampin: Emphasis on the Relation to PhagocytesClinical Infectious Diseases, 1983
- Chronic Staphylococcal Osteomyelitis: Treatment with Regimens Containing RifampinClinical Infectious Diseases, 1983
- Pharmacokinetics and Metabolism of Rifampin in HumansClinical Infectious Diseases, 1983